Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
|Articles|May 18, 2022
Daily OTC Pearl: Docusate Sodium
Author(s)Saro Arakelians, PharmD
Docusate treats occasional constipation by reducing surface tension and emulsification of fecal matter, which allows water to penetrate and mix with and soften stool.
Advertisement
OTC/Lifestyle Pearl of the Day: Docusate Sodium
Indication: Docusate treats occasional constipation by reducing surface tension and emulsification of fecal matter, which allows water to penetrate and mix with and soften stool.
Insight:
- Contains extra strength docusate sodium 250 mg.
- Often the first method used for preventing and treating occasional constipation.
- Take 1 softgel per day.
- Docusate sodium 250 mg works by increasing the amount of water the stool absorbs in the gut, thereby softening the stool and making it easier to pass.
- Constipation relief for adults and children 2 years of age and over.
- This stool softener laxative comes in a convenient softgel and is gluten free.
- Stimulant free, predictable relief of occasional constipation symptoms.
Source:
Advertisement
Related to this article
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
This article discusses a recent publication examining pharmacy access across Minnesota and explores the complex factors contributing to threatened community health access across the US.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
4
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
5